These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23422387)

  • 1. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report.
    Zigman D; Blier P
    J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous Ketamine as an Effective and Safe Treatment in a Suicidal Patient With Cancer Who Was Nil Per Os.
    Rajagukguk S; Lee T
    Psychosomatics; 2020; 61(4):371-374. PubMed ID: 31739996
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    Gurnani T; Khurshid KA
    Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder.
    Womble AL
    AANA J; 2013 Apr; 81(2):118-9. PubMed ID: 23971230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation.
    Zhan Y; Zhang B; Zhou Y; Zheng W; Liu W; Wang C; Li H; Chen L; Yu L; Walter M; Li M; Li MD; Ning Y
    J Affect Disord; 2019 May; 251():205-212. PubMed ID: 30927581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine for the treatment of depression: what about the addictive potential?
    Hillemacher T; Bleich S; Demling J; Kornhuber J
    Aust N Z J Psychiatry; 2007 Sep; 41(9):772-3. PubMed ID: 17896416
    [No Abstract]   [Full Text] [Related]  

  • 9. Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer.
    Zanicotti CG; Perez D; Glue P
    J Palliat Med; 2012 Apr; 15(4):400-3. PubMed ID: 22468772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting.
    Sinyor M; Williams M; Belo S; Orser B; Vincent M; Mah L; Zarate C; Castel S; Levitt AJ; Schaffer A
    J Affect Disord; 2018 Dec; 241():103-109. PubMed ID: 30107350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine as treatment for depression.
    Taiminen T
    Duodecim; 2017; 133(1):52-60. PubMed ID: 29199810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression.
    Liebrenz M; Stohler R; Borgeat A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):640-3. PubMed ID: 17853274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study.
    Włodarczyk A; Cubała WJ; Gałuszko-Węgielnik M; Szarmach J
    Medicine (Baltimore); 2021 Jul; 100(29):e26769. PubMed ID: 34398056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychopharmacol; 2019 Apr; 33(4):494-501. PubMed ID: 30789302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Suicidal Ideation During Intravenous Ketamine Treatment.
    Smith AWT; Virk S
    Am J Ther; 2019; 26(6):e732-e735. PubMed ID: 30946043
    [No Abstract]   [Full Text] [Related]  

  • 16. Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.
    Pérez-Esparza R; Kobayashi-Romero LF; García-Mendoza AM; Lamas-Aguilar RM; Fonseca-Perezamador A
    Acta Psychiatr Scand; 2019 Aug; 140(2):182-183. PubMed ID: 31251388
    [No Abstract]   [Full Text] [Related]  

  • 17. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
    Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ
    Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
    Phillips JL; Norris S; Talbot J; Hatchard T; Ortiz A; Birmingham M; Owoeye O; Batten LA; Blier P
    Neuropsychopharmacology; 2020 Mar; 45(4):606-612. PubMed ID: 31759333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
    Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA
    J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research suggests new drug targets for depression. Pilot studies of ketamine intrigue scientists, but risks of this anesthetic limit its clinical use.
    Harv Ment Health Lett; 2010 Nov; 27(5):6. PubMed ID: 21218614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.